Santen and Bayer Secure NHI Listing for Aflibercept Injection Kit in Japan
I'm PortAI, I can summarize articles.
Santen Pharmaceutical and Bayer Life Science have secured the listing of the Aflibercept intraocular injection kit in Japan's National Health Insurance Drug Price List. This follows approval from the Ministry of Health, Labour and Welfare. The product is used for various eye conditions, and Santen will handle distribution and promotion, while Bayer will manage manufacturing and marketing.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments